Early Access — free while we kick the tires
EdgarHawk

Ambrose Kristen

SVP & Chief Accounting Officer

Officer
1 filing analyzed · 1 company · Latest 2026-02-19

Companies

Company Buys Sells Direction
VERTEX PHARMACEUTICALS INC / MA VRTX 0 4 Net selling

Activity

February 2026
Sell
2,195 shares
$1,064,297
Significance 4/10

Ambrose Kristen (SVP & Chief Accounting Officer) sells 2,195 shares for $1,064,297.06 across 2 transactions at VRTX

Ambrose Kristen executed 2 separate sales totaling 2,195 shares for $1,064,297.06 on 2026-02-17 and 2026-02-18, at prices of $489.46 and $473.68 respectively (blended average $484.87). Post-transaction holdings stand at 7,750 shares, representing a 22.1% reduction from the pre-transaction 9,945 shares. The current market price of $469.27 sits 8.7% below the 52-week high of $513.76, and the sales executed near the peak of the recent range, with the first sale at $489.46 trading well above current levels. This activity reflects a material portfolio adjustment by a senior accounting officer at a profitable company with strong fundamentals (P/E 14.60, annual revenue growth of 8.9%), though without disclosed trading plan or plan characteristics in the filing, the timing relative to recent price momentum (90-day change +10.0%) provides limited directional signal.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access